scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0022-5347(17)35944-X |
P698 | PubMed publication ID | 8230543 |
P50 | author | Douglas Yee | Q56985470 |
P2093 | author name string | D D von Hoff | |
M F Sarosdy | |||
D H Hutzler | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1950-1955 | |
P577 | publication date | 1993-12-01 | |
P1433 | published in | Journal of Urology | Q15709979 |
P1476 | title | In vitro sensitivity testing of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity | |
P478 | volume | 150 |
Q36108466 | Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors |
Q41442987 | Growth factors in bladder cancer |
Q26751473 | Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers |
Q41022992 | Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges. |
Q47231221 | The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations. |
Q41229172 | Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line |
Q39991480 | Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor |
Search more.